Indiana expands COVID-19 vaccine eligibility to those with certain medical conditions

The Indiana Department of Health has expanded eligibility for the COVID-19 vaccine to those with certain medical conditions.

Before you can make an appointment, your healthcare provider will submit your information to department, then  you will receive a text message and/or email with a unique link that will allow you to sign up for an appointment.

You are encouraged to speak with your health care provider to make sure your medications won’t interfere with the vaccine, and that they have your correct phone number and/or email address.

You may receive a letter with more details in the future. You will need to take the letter with you to your appointment unless you sign up with your unique link.

After you get a message or letter you can also call 211 to make an appointment.

Teens who are 16 or 17 years old will need to sign up with sites offering the Pfizer vaccine.

Eligible medical conditions :

  • Active dialysis patients
  • Sickle cell disease patients
  • Down syndrome
  • Post-solid organ transplant
  • People who are actively in treatment (chemotherapy, radiation, surgery) for cancer now or in the last three months, or with active primary lung cancer or active hematologic cancers; lymphoma, leukemia and multiple myeloma
  • Early childhood conditions that are carried into adulthood:
    • Cystic fibrosis
    • Muscular dystrophy
    • People born with severe heart defects, requiring specialized medical care.
    • People with severe type 1 diabetes, who have been hospitalized in the past year.
    • Phenylketonuria (PKU), Tay-Sachs, and other rare, inherited metabolic disorders.
    • Epilepsy with continuing seizures, hydrocephaly, microcephaly and other severe neurologic disorders
    • People with severe asthma who have been hospitalized for this in the past year
    • Alpha and beta thalassemia
    • Spina bifida
    • Cerebral palsy
  • People who require supplemental oxygen and/or tracheostomy
  • Pulmonary fibrosis, Alpha-1 Antitrypsin
  • Immunocompromised state (weakened immune system) from blood or bone marrow transplant, immune deficiencies, combined primary immunodeficiency disorder, HIV, daily use of corticosteroids, use of other immune weakening medicines, receiving tumor necrosis factor-alpha blocker or rituximab.
  • Intellectual and Developmentally Disabled individuals receiving home/community-based services. (Family and Social Services Administration will provide patient information for this community.)

Visit for more information on the COVID-19 vaccine.

Share this article: